Lloyd Mackenzie News Today

NervGen Pharma Corp.: NervGen Pharma Reports 2020 Year End Results Vancouver, British Columbia--(Newsfile Corp. - April 8, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today reported its financial results for the year ended December 31, 2020. Paul Brennan, NervGens President & CEO, stated, "We made substantial progress in the de...

COVID-19 swab in lab Photo: Getty Images A Burnaby biotech company is partnering with a global pharmaceutical giant on research into advancing delivery of oral vaccines, including for COVID-19. Symvivo Corporation, a clinical-stage biotechnology company that has a proprietary bacTRL gene delivery platform, announced Tuesday that it has entered into a research collaboration with Merck Sharp and Dohme Corp. Under the terms of the agreement, Merck receives an option to take an exclusive license to...